Evidence map›Paper›PMID 26290246›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.

Suresh D Muthukumaraswamy, Alexander D Shaw, Laura E Jackson, Judith Hall, Rosalyn Moran, Neeraj Saxena

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 239 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  6. Trial
  7. Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2020
    Trial
  8. Trial
  9. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Suresh D MuthukumaraswamySchools of Pharmacy and Psychology, The University of Auckland, Auckland 1142, New Zealand, sd.muthu@auckland.ac.nz.
Alexander D ShawCardiff University Brain Research Imaging Centre, Cardiff University, Cardiff CF103AT, United Kingdom.ORCID http://orcid.org/0000-0001-5741-7526
Laura E JacksonDepartment of Anaesthetics, Intensive Care and Pain Medicine, Cwm Taf University Health Board, Llantrisant CF72 8XR, United Kingdom.ORCID http://orcid.org/0000-0002-0263-9479
Judith HallDepartment of Anaesthetics, Intensive Care and Pain Medicine, Cwm Taf University Health Board, Llantrisant CF72 8XR, United Kingdom.
Rosalyn MoranVirginia Tech Carilion Research Institute, Bradley Department of Electrical and Computer Engineering, Roanoke, Virginia 24016, and.
Neeraj SaxenaDepartment of Anaesthetics, Intensive Care and Pain Medicine, Cwm Taf University Health Board, Llantrisant CF72 8XR, United Kingdom, Department of Anaesthetics, Intensive Care and Pain Medicine, School of Medicine, Cardiff University, Cardiff CF144XW, United Kingdom.
Cwm Taf University Health Board · GBCardiff University · GBCarilion Clinic · USUniversity of Auckland · NZ

Funding

Medical Research Council MR/K005464/1
6 · The paper itself

Abstract

Following the discovery of the antidepressant properties of ketamine, there has been a recent resurgence in the interest in this NMDA receptor antagonist. Although detailed animal models of the molecular mechanisms underlying ketamine's effects have emerged, there are few MEG/EEG studies examining the acute subanesthetic effects of ketamine infusion in man. We recorded 275 channel MEG in two experiments (n = 25 human males) examining the effects of subanesthetic ketamine infusion. MEG power spectra revealed a rich set of significant oscillatory changes compared with placebo sessions, including decreases in occipital, parietal, and anterior cingulate alpha power, increases in medial frontal theta power, and increases in parietal and cingulate cortex high gamma power. Each of these spectral effects demonstrated their own set of temporal dynamics. Dynamic causal modeling of frontoparietal connectivity changes with ketamine indicated a decrease in NMDA and AMPA-mediated frontal-to-parietal connectivity. AMPA-mediated connectivity changes were sustained for up to 50 min after ketamine infusion had ceased, by which time perceptual distortions were absent. The results also indicated a decrease in gain of parietal pyramidal cells, which was correlated with participants' self-reports of blissful state. Based on these results, we suggest that the antidepressant effects of ketamine may depend on its ability to change the balance of frontoparietal connectivity patterns. SIGNIFICANCE STATEMENT: In this paper, we found that subanesthetic doses of ketamine, similar to those used in antidepressant studies, increase anterior theta and gamma power but decrease posterior theta, delta, and alpha power, as revealed by magnetoencephalographic recordings. Dynamic causal modeling of frontoparietal connectivity changes with ketamine indicated a decrease in NMDA and AMPA-mediated frontal-to-parietal connectivity. AMPA-mediated connectivity changes were sustained for up to 50 min after ketamine infusion had ceased, by which time perceptual distortions were absent. The results also indicated a decrease in gain of parietal pyramidal cells, which was correlated with participants' self-reports of blissful state. The alterations in frontoparietal connectivity patterns we observe here may be important in generating the antidepressant response to ketamine.

Indexed as

AdultAnesthetics, DissociativeAntidepressive AgentsBrain MappingBrain WavesDose-Response Relationship, DrugFrontal LobeHumansKetamineMaleNeural PathwaysParietal LobeReceptors, AMPAReceptors, N-Methyl-D-AspartateYoung AdultAnesthetics, DissociativeAntidepressive AgentsKetamineReceptors, AMPAReceptors, N-Methyl-D-Aspartatealpha rhythmsdepressiondynamic causal modellinggamma rhythmsketaminemagnetoencephalography

Identifiers

PMID26290246
PMCPMC4540803
OpenAlexW1953260479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.